Mechanism of azole antifungal activity as determined by liquid chromatographic/mass spectrometric monitoring of ergosterol biosynthesis

Journal of Mass Spectrometry : JMS
Larry HeimarkBirendra N Pramanik

Abstract

A liquid chromatography/mass spectrometry (LC/MS) method for separation and characterization of ergosterol biosynthetic precursors was developed to study the effect of Posaconazole on sterol biosynthesis in fungi. Ergosterol biosynthetic precursors were characterized from their electron ionization mass spectra acquired by a normal-phase chromatography, particle beam LC/MS method. Fragment ions resulting from cleavage across the D-ring and an abundant M - 15 fragment ion were diagnostic for methyl substitution at C-4 and C-14. Comparison of the sterol profile in control and treated Candida albicans incubations showed depletion of ergosterol and accumulation of C-4 and C-14 methyl-substituted sterols following treatment with Posaconazole. These C-4 and C-14 methyl sterols are known to be incapable of sustaining cell growth. The results demonstrate that Posaconazole exerts its antifungal activity by inhibition of ergosterol biosynthesis. Furthermore, Posaconazole appears to disrupt ergosterol biosynthesis by inhibition of lanosterol 14alpha-demethylase.

Citations

Jan 24, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Daniel J SkiestRandi Isaacs
Jan 15, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vijayalakshmi Nagappan, Stan Deresinski
Sep 25, 2004·Antimicrobial Agents and Chemotherapy·Hanan K MunayyerPaul M McNicholas
Jul 31, 2007·Future Microbiology·Jose A Vazquez
Aug 19, 2005·Expert Review of Anti-infective Therapy·Andreas H Groll, Thomas J Walsh
May 23, 2007·Expert Opinion on Pharmacotherapy·Douglas S Kwon, Eleftherios Mylonakis
Jan 8, 2016·Infectious Disease Clinics of North America·Jeniel E Nett, David R Andes
Mar 27, 2003·Molecular Microbiology·Manuela Schuetzer-MuehlbauerKarl Kuchler
Apr 20, 2006·Journal of Pharmaceutical and Biomedical Analysis·M J LagardaR Farré
Apr 11, 2018·Antimicrobial Agents and Chemotherapy·Rocio Garcia-RubioEmilia Mellado
Jul 12, 2002·Journal of Mass Spectrometry : JMS
Oct 21, 2015·Pharmacy : Journal of Pharmacy, Education and Practice·Simon LeungJade Machin
May 20, 2020·Frontiers in Cellular and Infection Microbiology·Minji ParkWon Hee Jung
Mar 12, 2021·G3 : Genes - Genomes - Genetics·Elizabeth W HunsakerKatherine J Franz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.